T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Neurocrine Biosciences
NBIX
$15.9B
| $225M | 0.05% |
10,069,239
+85,600
| +0.9% | +$1.62M |
|
|
CIT
402
DELISTED
CIT Group Inc.
CIT
| $225M | 0.05% |
4,701,187
-1,425,953
| -23% | -$67.7M |
|
|
DTV
403
DELISTED
DIRECTV COM STK (DE)
DTV
| $225M | 0.05% |
2,590,912
+192,933
| +8% | +$16.6M |
|
404
CoStar Group
CSGP
$12.4B
| $224M | 0.05% |
12,210,960
-703,000
| -5% | -$11.4M |
|
405
PPG Industries
PPG
$25.5B
| $224M | 0.05% |
1,935,802
+1,436,240
| +287% | +$149M |
|
406
Flowers Foods
FLO
$1.52B
| $222M | 0.05% |
11,590,229
-5,475,506
| -32% | -$103M |
|
407
Acadia Realty Trust
AKR
$2.84B
| $222M | 0.05% |
6,938,070
+474,600
| +7% | +$14.7M |
|
|
EVHC
408
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $222M | 0.05% |
2,139,604
+170,564
| +9% | +$17.6M |
|
|
CYT
409
DELISTED
CYTEC INDS INC
CYT
| $218M | 0.05% |
4,718,609
+1,492,137
| +46% | +$69.4M |
|
410
Cintas
CTAS
$81.4B
| $217M | 0.05% |
11,065,744
-717,200
| -6% | -$13M |
|
411
SBA Communications
SBAC
$19.4B
| $216M | 0.05% |
1,951,462
-511,101
| -21% | -$57.5M |
|
|
DO
412
DELISTED
Diamond Offshore Drilling
DO
| $215M | 0.05% |
5,855,852
+4,300
| +0.1% | +$154K |
|
|
MRO
413
DELISTED
Marathon Oil Corporation
MRO
| $215M | 0.05% |
7,584,321
-1,209,736
| -14% | -$38.5M |
|
|
ABCO
414
DELISTED
Advisory Board Co
ABCO
| $211M | 0.04% |
4,315,786
+317,902
| +8% | +$15M |
|
415
CNA Financial
CNA
$13.7B
| $211M | 0.04% |
5,453,138
+236,698
| +5% | +$9.09M |
|
|
FNFG
416
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $211M | 0.04% |
25,035,088
+4,036,108
| +19% | +$32.5M |
|
417
Kimco Realty
KIM
$16.2B
| $210M | 0.04% |
8,339,086
+58,430
| +0.7% | +$1.43M |
|
418
BP
BP
$111B
| $208M | 0.04% |
6,574,176
-60,425
| -0.9% | -$2.03M |
|
419
White Mountains Insurance
WTM
$5.06B
| $207M | 0.04% |
328,771
| – | – |
|
|
PSB
420
DELISTED
PS Business Parks, Inc.
PSB
| $207M | 0.04% |
2,603,470
+98,806
| +4% | +$7.95M |
|
|
FLTX
421
DELISTED
Fleetmatics Group PLC
FLTX
| $206M | 0.04% |
5,807,393
-471,707
| -8% | -$16.2M |
|
422
Altria Group
MO
$107B
| $206M | 0.04% |
4,180,535
-48,110
| -1% | -$2.34M |
|
|
TXNM
423
TXNM Energy Inc
TXNM
$5.91B
| $206M | 0.04% |
6,949,202
+528,770
| +8% | +$15M |
|
424
Goldman Sachs
GS
$302B
| $206M | 0.04% |
1,061,663
-333,946
| -24% | -$62.8M |
|
|
SCHW
425
Charles Schwab
SCHW
$189B
| $205M | 0.04% |
6,800,902
-18,260
| -0.3% | -$519K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.